Saturday, December 3, 2022
HomePharma

Pharma

Pharma

BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Chronic Lymphocytic Leukemia (CLL)

Life Sciences Times - 0
Pharma

Biomind Labs Announces FDA Investigational New Drug Clearance for Its New Chemical Entity Triptax™ Targeting Treatment-Resistant Depression

Life Sciences Times - 0
Pharma

PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns

Life Sciences Times - 0
Pharma

Appili Therapeutics ATI-1701 Biodefense Vaccine Secures ~US$14 Million of Funding from the U.S. Department of Defense in Partnership with the U.S. Air Force Academy

Life Sciences Times - 0
Pharma

World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.

Life Sciences Times - 0
Pharma

Aimmune Therapeutics to Present Positive Results from Phase 3 POSEIDON Study of PALFORZIA

Life Sciences Times - 0
Pharma

BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers

Life Sciences Times - 0
Pharma

Qnovia to Pursue UK Approval for Lead Asset QN-01 in Nicotine Replacement Therapy

Life Sciences Times - 0
Pharma

Silence Therapeutics Presents New Analysis from SLN360 Phase 1 Single Dose Study in High Lipoprotein(a)

Life Sciences Times - 0
Pharma

Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis

Life Sciences Times - 0
Pharma

U.S. Food and Drug Administration Approves Vemlidy® (tenofovir alafenamide) for Treatment of Chronic Hepatitis B Virus Infection in Pediatric Patients

Life Sciences Times - 0
Pharma

Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide

Life Sciences Times - 0
123...46Page 1 of 46

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv